WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 302
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 362

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 53  53  53  53  53  52  47  31 
Surviving infants
Pop. less than 5 years
Pop. less than 15 years 16  16  16  16  16  18  17  12 
Female 15-49 years 13  13  13  13  13  14  12 

Number of reported cases

(Click for retrospective incidence data for Marshall Islands (the))
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  14 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Marshall Islands (the))
Vaccine year result method % card seen                                                
BCG 2006  70  DHS   75  99*  89  93  97  89  49 
DTP1 2006  71  DHS   75  95  97  73  97  23 
DTP3 2006  48  DHS   75  85  78  36  80  39  92 
DTP4          75  53 
IPV1          95 
HepB_BD          99*  76  70  85  99* 
HepB3          85  79  41  80  38 
Hib3          70  65  21  67  45 
JapEnc          13 
MCV1          75  79  70  78  94  52 
MCV2          70  53  42  58 
PCV1          95  70  72  83 
PCV3          75  29  22  46 
Pol3 2006  46  DHS   75  85  77  36  80  36  89 
Rota1          95  65  71  73 
RotaC          90  44  45  60 
Rubella1          75  79  70  78 
TT2plus 2006  20  DHS   75  57  95  63  53 
PAB         
VAD1          13  36  95 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Marshall Islands (the))
BCG
ChartChart
  89  93  97  98  89  49 
DTP1
ChartChart
  97  97  97  99  64  97 
DTP3
ChartChart
  78  79  80  87  39  92 
HepB3
ChartChart
  79  80  80  89  38  10 
HepB_BD
ChartChart
  76  81  85  92  99 
Hib3
ChartChart
  65  66  67  80  45 
MCV1
ChartChart
  79  79  78  88  94  52 
MCV2
ChartChart
  53  56  58  74 
PCV3
ChartChart
  29  38  46  35 
Pol3
ChartChart
  77  79  80  88  36  89 
RotaC
ChartChart
  44  52  60  43 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 33
From 80 to 89% 0
From 50 to 79% 67
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 2, 4, 6, 12 months; 4-6 years; Yes
DTaPHepIPV 2, 4, 6 months; Yes
DTaPHibIPV 2, 4, 6 months; Yes
HPV 11-12 years; Yes girls
HepB_Pediatric birth; 2, 6, months; Yes
Hib 2, 4, 12 months; Yes
IPV 2, 4, 6 months; 4-6 years; Yes
Influenza_Adult >= 50 years; Yes and adults with chronic illness, pregnant women and health care workers
Influenza_Pediatric 6 months to 4 years; Yes and children with chronic illness
MMR 12, 13 months; Yes
MenC_conj 11-12 years; Yes
Pneumo_conj 2, 4, 6, 12 months; Yes
Rotavirus 2, 4, 6, 12 months; Yes
Td Yes every 10 years
Tdap 11-12 years; (x2) Yes
VitaminA 6-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   
What years does the MYP cover? number 2008-2014  2008-2014  2008-2012  2012-2014  2008-2012  2008-2012   
Nº of districts with microplans that include activities to raise immunization coverage number    

System performance

Total Nº districts in country number    
Nº districts with DTP3 coverage >=80% number    
% of districts with DTP3 coverage >=80% From 0 to 100%   100  100  33    100   
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%   100       

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  Yes   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  10   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR       No  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.